Snapzu Science
Monday, 11 July 2016
In clinical trials, for-profit review boards staged a revolution
The rise of commercial institutional review boards has led to questions over whether they can adequately protect the safety of study participants. By Sheila Kaplan. (July 6, 2016)
Continue reading...
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment